Overview

Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The study aims to determine what effect a high fat meal will have on the drug exposure of PF-04449913. The study also aims to determine the effect of a strong enzyme (CYP3A4) inhibitor on drug exposure of PF-04449913.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Ketoconazole